Global Amlodipine Besylate Sales Market Report 2021

Publisher Name :
Date: 19-Apr-2021
No. of pages: 145
Inquire Before Buying

The global Amlodipine Besylate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amlodipine Besylate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- 2.5mg Tablets

- 5mg Tablets

- 10mg Tablets

Segment by Application

- High Blood Pressure

- Heart Disease

The Amlodipine Besylate market is analysed and market size information is provided by regions (countries). Segment by Application, the Amlodipine Besylate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Pfizer

- Mylan

- Dr. Reddy's Laboratories

- Apotex

- Teva Pharmaceutical

- Cipla

- Hikma Pharmaceuticals

- Strides Pharma

- Upsher-Smith Laboratories

- InvaGen Pharmaceuticals

- Sun Pharmaceutical

- Aurobindo Pharma

- Lupin Pharmaceuticals

- Zydus Pharmaceuticals

- Oxford Pharm

- Wockhardt

- Epic Pharma

- CR Pharmaceutical

- Alkem Laboratories

- MACLEODS

Global Amlodipine Besylate Sales Market Report 2021

Table of Contents
1 Amlodipine Besylate Market Overview
1.1 Amlodipine Besylate Product Scope
1.2 Amlodipine Besylate Segment by Type
1.2.1 Global Amlodipine Besylate Sales by Type (2016 & 2021 & 2027)
1.2.2 2.5mg Tablets
1.2.3 5mg Tablets
1.2.4 10mg Tablets
1.3 Amlodipine Besylate Segment by Application
1.3.1 Global Amlodipine Besylate Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 High Blood Pressure
1.3.3 Heart Disease
1.4 Amlodipine Besylate Market Estimates and Forecasts (2016-2027)
1.4.1 Global Amlodipine Besylate Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Amlodipine Besylate Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Amlodipine Besylate Price Trends (2016-2027)
2 Amlodipine Besylate Estimates and Forecasts by Region
2.1 Global Amlodipine Besylate Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Amlodipine Besylate Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Amlodipine Besylate Sales Market Share by Region (2016-2021)
2.2.2 Global Amlodipine Besylate Revenue Market Share by Region (2016-2021)
2.3 Global Amlodipine Besylate Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Amlodipine Besylate Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Amlodipine Besylate Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Amlodipine Besylate Estimates and Projections (2016-2027)
2.4.2 Europe Amlodipine Besylate Estimates and Projections (2016-2027)
2.4.3 China Amlodipine Besylate Estimates and Projections (2016-2027)
2.4.4 Japan Amlodipine Besylate Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Amlodipine Besylate Estimates and Projections (2016-2027)
2.4.6 India Amlodipine Besylate Estimates and Projections (2016-2027)
3 Global Amlodipine Besylate Competition Landscape by Players
3.1 Global Top Amlodipine Besylate Players by Sales (2016-2021)
3.2 Global Top Amlodipine Besylate Players by Revenue (2016-2021)
3.3 Global Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amlodipine Besylate as of 2020)
3.4 Global Amlodipine Besylate Average Price by Company (2016-2021)
3.5 Manufacturers Amlodipine Besylate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Amlodipine Besylate Market Size by Type
4.1 Global Amlodipine Besylate Historic Market Review by Type (2016-2021)
4.1.1 Global Amlodipine Besylate Sales Market Share by Type (2016-2021)
4.1.2 Global Amlodipine Besylate Revenue Market Share by Type (2016-2021)
4.1.3 Global Amlodipine Besylate Price by Type (2016-2021)
4.2 Global Amlodipine Besylate Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Amlodipine Besylate Sales Forecast by Type (2022-2027)
4.2.2 Global Amlodipine Besylate Revenue Forecast by Type (2022-2027)
4.2.3 Global Amlodipine Besylate Price Forecast by Type (2022-2027)
5 Global Amlodipine Besylate Market Size by Application
5.1 Global Amlodipine Besylate Historic Market Review by Application (2016-2021)
5.1.1 Global Amlodipine Besylate Sales Market Share by Application (2016-2021)
5.1.2 Global Amlodipine Besylate Revenue Market Share by Application (2016-2021)
5.1.3 Global Amlodipine Besylate Price by Application (2016-2021)
5.2 Global Amlodipine Besylate Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Amlodipine Besylate Sales Forecast by Application (2022-2027)
5.2.2 Global Amlodipine Besylate Revenue Forecast by Application (2022-2027)
5.2.3 Global Amlodipine Besylate Price Forecast by Application (2022-2027)
6 North America Amlodipine Besylate Market Facts & Figures
6.1 North America Amlodipine Besylate Sales by Company
6.1.1 North America Amlodipine Besylate Sales by Company (2016-2021)
6.1.2 North America Amlodipine Besylate Revenue by Company (2016-2021)
6.2 North America Amlodipine Besylate Sales Breakdown by Type
6.2.1 North America Amlodipine Besylate Sales Breakdown by Type (2016-2021)
6.2.2 North America Amlodipine Besylate Sales Breakdown by Type (2022-2027)
6.3 North America Amlodipine Besylate Sales Breakdown by Application
6.3.1 North America Amlodipine Besylate Sales Breakdown by Application (2016-2021)
6.3.2 North America Amlodipine Besylate Sales Breakdown by Application (2022-2027)
7 Europe Amlodipine Besylate Market Facts & Figures
7.1 Europe Amlodipine Besylate Sales by Company
7.1.1 Europe Amlodipine Besylate Sales by Company (2016-2021)
7.1.2 Europe Amlodipine Besylate Revenue by Company (2016-2021)
7.2 Europe Amlodipine Besylate Sales Breakdown by Type
7.2.1 Europe Amlodipine Besylate Sales Breakdown by Type (2016-2021)
7.2.2 Europe Amlodipine Besylate Sales Breakdown by Type (2022-2027)
7.3 Europe Amlodipine Besylate Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Amlodipine Besylate Market Facts & Figures
8.1 China Amlodipine Besylate Sales by Company
8.1.1 China Amlodipine Besylate Sales by Company (2016-2021)
8.1.2 China Amlodipine Besylate Revenue by Company (2016-2021)
8.2 China Amlodipine Besylate Sales Breakdown by Type
8.2.1 China Amlodipine Besylate Sales Breakdown by Type (2016-2021)
8.2.2 China Amlodipine Besylate Sales Breakdown by Type (2022-2027)
8.3 China Amlodipine Besylate Sales Breakdown by Application
8.3.1 China 174 Sales Breakdown by Application (2016-2021)
8.3.2 China 174 Sales Breakdown by Application (2022-2027)
9 Japan Amlodipine Besylate Market Facts & Figures
9.1 Japan Amlodipine Besylate Sales by Company
9.1.1 Japan Amlodipine Besylate Sales by Company (2016-2021)
9.1.2 Japan Amlodipine Besylate Revenue by Company (2016-2021)
9.2 Japan Amlodipine Besylate Sales Breakdown by Type
9.2.1 Japan Amlodipine Besylate Sales Breakdown by Type (2016-2021)
9.2.2 Japan Amlodipine Besylate Sales Breakdown by Type (2022-2027)
9.3 Japan Amlodipine Besylate Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Amlodipine Besylate Market Facts & Figures
10.1 Southeast Asia Amlodipine Besylate Sales by Company
10.1.1 Southeast Asia Amlodipine Besylate Sales by Company (2016-2021)
10.1.2 Southeast Asia Amlodipine Besylate Revenue by Company (2016-2021)
10.2 Southeast Asia Amlodipine Besylate Sales Breakdown by Type
10.2.1 Southeast Asia Amlodipine Besylate Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Amlodipine Besylate Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Amlodipine Besylate Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Amlodipine Besylate Market Facts & Figures
11.1 India Amlodipine Besylate Sales by Company
11.1.1 India Amlodipine Besylate Sales by Company (2016-2021)
11.1.2 India Amlodipine Besylate Revenue by Company (2016-2021)
11.2 India Amlodipine Besylate Sales Breakdown by Type
11.2.1 India Amlodipine Besylate Sales Breakdown by Type (2016-2021)
11.2.2 India Amlodipine Besylate Sales Breakdown by Type (2022-2027)
11.3 India Amlodipine Besylate Sales Breakdown by Application
11.3.1 India Amlodipine Besylate Sales Breakdown by Application (2016-2021)
11.3.2 India Amlodipine Besylate Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Amlodipine Besylate Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Amlodipine Besylate Products Offered
12.1.5 Pfizer Recent Development
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Business Overview
12.2.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Mylan Amlodipine Besylate Products Offered
12.2.5 Mylan Recent Development
12.3 Dr. Reddy's Laboratories
12.3.1 Dr. Reddy's Laboratories Corporation Information
12.3.2 Dr. Reddy's Laboratories Business Overview
12.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Dr. Reddy's Laboratories Amlodipine Besylate Products Offered
12.3.5 Dr. Reddy's Laboratories Recent Development
12.4 Apotex
12.4.1 Apotex Corporation Information
12.4.2 Apotex Business Overview
12.4.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Apotex Amlodipine Besylate Products Offered
12.4.5 Apotex Recent Development
12.5 Teva Pharmaceutical
12.5.1 Teva Pharmaceutical Corporation Information
12.5.2 Teva Pharmaceutical Business Overview
12.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Pharmaceutical Amlodipine Besylate Products Offered
12.5.5 Teva Pharmaceutical Recent Development
12.6 Cipla
12.6.1 Cipla Corporation Information
12.6.2 Cipla Business Overview
12.6.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Cipla Amlodipine Besylate Products Offered
12.6.5 Cipla Recent Development
12.7 Hikma Pharmaceuticals
12.7.1 Hikma Pharmaceuticals Corporation Information
12.7.2 Hikma Pharmaceuticals Business Overview
12.7.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hikma Pharmaceuticals Amlodipine Besylate Products Offered
12.7.5 Hikma Pharmaceuticals Recent Development
12.8 Strides Pharma
12.8.1 Strides Pharma Corporation Information
12.8.2 Strides Pharma Business Overview
12.8.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Strides Pharma Amlodipine Besylate Products Offered
12.8.5 Strides Pharma Recent Development
12.9 Upsher-Smith Laboratories
12.9.1 Upsher-Smith Laboratories Corporation Information
12.9.2 Upsher-Smith Laboratories Business Overview
12.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Upsher-Smith Laboratories Amlodipine Besylate Products Offered
12.9.5 Upsher-Smith Laboratories Recent Development
12.10 InvaGen Pharmaceuticals
12.10.1 InvaGen Pharmaceuticals Corporation Information
12.10.2 InvaGen Pharmaceuticals Business Overview
12.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.10.4 InvaGen Pharmaceuticals Amlodipine Besylate Products Offered
12.10.5 InvaGen Pharmaceuticals Recent Development
12.11 Sun Pharmaceutical
12.11.1 Sun Pharmaceutical Corporation Information
12.11.2 Sun Pharmaceutical Business Overview
12.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sun Pharmaceutical Amlodipine Besylate Products Offered
12.11.5 Sun Pharmaceutical Recent Development
12.12 Aurobindo Pharma
12.12.1 Aurobindo Pharma Corporation Information
12.12.2 Aurobindo Pharma Business Overview
12.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Aurobindo Pharma Amlodipine Besylate Products Offered
12.12.5 Aurobindo Pharma Recent Development
12.13 Lupin Pharmaceuticals
12.13.1 Lupin Pharmaceuticals Corporation Information
12.13.2 Lupin Pharmaceuticals Business Overview
12.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Lupin Pharmaceuticals Amlodipine Besylate Products Offered
12.13.5 Lupin Pharmaceuticals Recent Development
12.14 Zydus Pharmaceuticals
12.14.1 Zydus Pharmaceuticals Corporation Information
12.14.2 Zydus Pharmaceuticals Business Overview
12.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Zydus Pharmaceuticals Amlodipine Besylate Products Offered
12.14.5 Zydus Pharmaceuticals Recent Development
12.15 Oxford Pharm
12.15.1 Oxford Pharm Corporation Information
12.15.2 Oxford Pharm Business Overview
12.15.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Oxford Pharm Amlodipine Besylate Products Offered
12.15.5 Oxford Pharm Recent Development
12.16 Wockhardt
12.16.1 Wockhardt Corporation Information
12.16.2 Wockhardt Business Overview
12.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Wockhardt Amlodipine Besylate Products Offered
12.16.5 Wockhardt Recent Development
12.17 Epic Pharma
12.17.1 Epic Pharma Corporation Information
12.17.2 Epic Pharma Business Overview
12.17.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Epic Pharma Amlodipine Besylate Products Offered
12.17.5 Epic Pharma Recent Development
12.18 CR Pharmaceutical
12.18.1 CR Pharmaceutical Corporation Information
12.18.2 CR Pharmaceutical Business Overview
12.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.18.4 CR Pharmaceutical Amlodipine Besylate Products Offered
12.18.5 CR Pharmaceutical Recent Development
12.19 Alkem Laboratories
12.19.1 Alkem Laboratories Corporation Information
12.19.2 Alkem Laboratories Business Overview
12.19.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Alkem Laboratories Amlodipine Besylate Products Offered
12.19.5 Alkem Laboratories Recent Development
12.20 MACLEODS
12.20.1 MACLEODS Corporation Information
12.20.2 MACLEODS Business Overview
12.20.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
12.20.4 MACLEODS Amlodipine Besylate Products Offered
12.20.5 MACLEODS Recent Development
13 Amlodipine Besylate Manufacturing Cost Analysis
13.1 Amlodipine Besylate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Amlodipine Besylate
13.4 Amlodipine Besylate Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Amlodipine Besylate Distributors List
14.3 Amlodipine Besylate Customers
15 Market Dynamics
15.1 Amlodipine Besylate Market Trends
15.2 Amlodipine Besylate Drivers
15.3 Amlodipine Besylate Market Challenges
15.4 Amlodipine Besylate Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Amlodipine Besylate Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Amlodipine Besylate Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Amlodipine Besylate Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Amlodipine Besylate Sales (K Units) by Region (2016-2021)
Table 5. Global Amlodipine Besylate Sales Market Share by Region (2016-2021)
Table 6. Global Amlodipine Besylate Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Amlodipine Besylate Revenue Share by Region (2016-2021)
Table 8. Global Amlodipine Besylate Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Amlodipine Besylate Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Amlodipine Besylate Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Amlodipine Besylate Revenue Share Forecast by Region (2022-2027)
Table 12. Global Amlodipine Besylate Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Amlodipine Besylate Sales Share by Company (2016-2021)
Table 14. Global Amlodipine Besylate Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Amlodipine Besylate Revenue Share by Company (2016-2021)
Table 16. Global Amlodipine Besylate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amlodipine Besylate as of 2020)
Table 17. Global Amlodipine Besylate Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Amlodipine Besylate Manufacturing Sites and Area Served
Table 19. Manufacturers Amlodipine Besylate Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Amlodipine Besylate Sales (K Units) by Type (2016-2021)
Table 22. Global Amlodipine Besylate Sales Share by Type (2016-2021)
Table 23. Global Amlodipine Besylate Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Amlodipine Besylate Price (USD/Unit) by Type (2016-2021)
Table 25. Global Amlodipine Besylate Sales Share by Type (2022-2027)
Table 26. Global Amlodipine Besylate Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Amlodipine Besylate Revenue Share by Type (2022-2027)
Table 28. Global Amlodipine Besylate Price (USD/Unit) by Type (2022-2027)
Table 29. Global Amlodipine Besylate Sales (K Units) by Application (2016-2021)
Table 30. Global Amlodipine Besylate Sales Share by Application (2016-2021)
Table 31. Global Amlodipine Besylate Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Amlodipine Besylate Price (USD/Unit) by Application (2016-2021)
Table 33. Global Amlodipine Besylate Sales (K Units) by Application (2022-2027)
Table 34. Global Amlodipine Besylate Sales Share by Application (2022-2027)
Table 35. Global Amlodipine Besylate Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Amlodipine Besylate Revenue Share by Application (2022-2027)
Table 37. Global Amlodipine Besylate Price (USD/Unit) by Application (2022-2027)
Table 38. North America Amlodipine Besylate Sales (K Units) by Company (2016-2021)
Table 39. North America Amlodipine Besylate Sales Market Share by Company (2016-2021)
Table 40. North America Amlodipine Besylate Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Amlodipine Besylate Revenue Market Share by Company (2016-2021)
Table 42. North America Amlodipine Besylate Sales by Type (2016-2021) & (K Units)
Table 43. North America Amlodipine Besylate Sales Market Share by Type (2016-2021)
Table 44. North America Amlodipine Besylate Sales by Type (2022-2027) & (K Units)
Table 45. North America Amlodipine Besylate Sales Market Share by Type (2022-2027)
Table 46. North America Amlodipine Besylate Sales by Application (2016-2021) & (K Units)
Table 47. North America Amlodipine Besylate Sales Market Share by Application (2016-2021)
Table 48. North America Amlodipine Besylate Sales by Application (2022-2027) & (K Units)
Table 49. North America Amlodipine Besylate Sales Market Share by Application (2022-2027)
Table 50. Europe Amlodipine Besylate Sales (K Units) by Company (2016-2021)
Table 51. Europe Amlodipine Besylate Sales Market Share by Company (2016-2021)
Table 52. Europe Amlodipine Besylate Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Amlodipine Besylate Revenue Market Share by Company (2016-2021)
Table 54. Europe Amlodipine Besylate Sales by Type (2016-2021) & (K Units)
Table 55. Europe Amlodipine Besylate Sales Market Share by Type (2016-2021)
Table 56. Europe Amlodipine Besylate Sales by Type (2022-2027) & (K Units)
Table 57. Europe Amlodipine Besylate Sales Market Share by Type (2022-2027)
Table 58. Europe Amlodipine Besylate Sales by Application (2016-2021) & (K Units)
Table 59. Europe Amlodipine Besylate Sales Market Share by Application (2016-2021)
Table 60. Europe Amlodipine Besylate Sales by Application (2022-2027) & (K Units)
Table 61. Europe Amlodipine Besylate Sales Market Share by Application (2022-2027)
Table 62. China Amlodipine Besylate Sales (K Units) by Company (2016-2021)
Table 63. China Amlodipine Besylate Sales Market Share by Company (2016-2021)
Table 64. China Amlodipine Besylate Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Amlodipine Besylate Revenue Market Share by Company (2016-2021)
Table 66. China Amlodipine Besylate Sales by Type (2016-2021) & (K Units)
Table 67. China Amlodipine Besylate Sales Market Share by Type (2016-2021)
Table 68. China Amlodipine Besylate Sales by Type (2022-2027) & (K Units)
Table 69. China Amlodipine Besylate Sales Market Share by Type (2022-2027)
Table 70. China Amlodipine Besylate Sales by Application (2016-2021) & (K Units)
Table 71. China Amlodipine Besylate Sales Market Share by Application (2016-2021)
Table 72. China Amlodipine Besylate Sales by Application (2022-2027) & (K Units)
Table 73. China Amlodipine Besylate Sales Market Share by Application (2022-2027)
Table 74. Japan Amlodipine Besylate Sales (K Units) by Company (2016-2021)
Table 75. Japan Amlodipine Besylate Sales Market Share by Company (2016-2021)
Table 76. Japan Amlodipine Besylate Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Amlodipine Besylate Revenue Market Share by Company (2016-2021)
Table 78. Japan Amlodipine Besylate Sales by Type (2016-2021) & (K Units)
Table 79. Japan Amlodipine Besylate Sales Market Share by Type (2016-2021)
Table 80. Japan Amlodipine Besylate Sales by Type (2022-2027) & (K Units)
Table 81. Japan Amlodipine Besylate Sales Market Share by Type (2022-2027)
Table 82. Japan Amlodipine Besylate Sales by Application (2016-2021) & (K Units)
Table 83. Japan Amlodipine Besylate Sales Market Share by Application (2016-2021)
Table 84. Japan Amlodipine Besylate Sales by Application (2022-2027) & (K Units)
Table 85. Japan Amlodipine Besylate Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Amlodipine Besylate Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Amlodipine Besylate Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Amlodipine Besylate Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Amlodipine Besylate Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Amlodipine Besylate Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Amlodipine Besylate Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Amlodipine Besylate Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Amlodipine Besylate Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Amlodipine Besylate Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Amlodipine Besylate Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Amlodipine Besylate Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Amlodipine Besylate Sales Market Share by Application (2022-2027)
Table 98. India Amlodipine Besylate Sales (K Units) by Company (2016-2021)
Table 99. India Amlodipine Besylate Sales Market Share by Company (2016-2021)
Table 100. India Amlodipine Besylate Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Amlodipine Besylate Revenue Market Share by Company (2016-2021)
Table 102. India Amlodipine Besylate Sales by Type (2016-2021) & (K Units)
Table 103. India Amlodipine Besylate Sales Market Share by Type (2016-2021)
Table 104. India Amlodipine Besylate Sales by Type (2022-2027) & (K Units)
Table 105. India Amlodipine Besylate Sales Market Share by Type (2022-2027)
Table 106. India Amlodipine Besylate Sales by Application (2016-2021) & (K Units)
Table 107. India Amlodipine Besylate Sales Market Share by Application (2016-2021)
Table 108. India Amlodipine Besylate Sales by Application (2022-2027) & (K Units)
Table 109. India Amlodipine Besylate Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pfizer Amlodipine Besylate Product
Table 114. Pfizer Recent Development
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Mylan Amlodipine Besylate Product
Table 119. Mylan Recent Development
Table 120. Dr. Reddy's Laboratories Corporation Information
Table 121. Dr. Reddy's Laboratories Description and Business Overview
Table 122. Dr. Reddy's Laboratories Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Dr. Reddy's Laboratories Amlodipine Besylate Product
Table 124. Dr. Reddy's Laboratories Recent Development
Table 125. Apotex Corporation Information
Table 126. Apotex Description and Business Overview
Table 127. Apotex Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Apotex Amlodipine Besylate Product
Table 129. Apotex Recent Development
Table 130. Teva Pharmaceutical Corporation Information
Table 131. Teva Pharmaceutical Description and Business Overview
Table 132. Teva Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Teva Pharmaceutical Amlodipine Besylate Product
Table 134. Teva Pharmaceutical Recent Development
Table 135. Cipla Corporation Information
Table 136. Cipla Description and Business Overview
Table 137. Cipla Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Cipla Amlodipine Besylate Product
Table 139. Cipla Recent Development
Table 140. Hikma Pharmaceuticals Corporation Information
Table 141. Hikma Pharmaceuticals Description and Business Overview
Table 142. Hikma Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Hikma Pharmaceuticals Amlodipine Besylate Product
Table 144. Hikma Pharmaceuticals Recent Development
Table 145. Strides Pharma Corporation Information
Table 146. Strides Pharma Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Strides Pharma Description and Business Overview
Table 148. Strides Pharma Amlodipine Besylate Product
Table 149. Strides Pharma Recent Development
Table 150. Upsher-Smith Laboratories Corporation Information
Table 151. Upsher-Smith Laboratories Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Upsher-Smith Laboratories Description and Business Overview
Table 153. Upsher-Smith Laboratories Amlodipine Besylate Product
Table 154. Upsher-Smith Laboratories Recent Development
Table 155. InvaGen Pharmaceuticals Corporation Information
Table 156. InvaGen Pharmaceuticals Description and Business Overview
Table 157. InvaGen Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. InvaGen Pharmaceuticals Amlodipine Besylate Product
Table 159. InvaGen Pharmaceuticals Recent Development
Table 160. Sun Pharmaceutical Corporation Information
Table 161. Sun Pharmaceutical Description and Business Overview
Table 162. Sun Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Sun Pharmaceutical Amlodipine Besylate Product
Table 164. Sun Pharmaceutical Recent Development
Table 165. Aurobindo Pharma Corporation Information
Table 166. Aurobindo Pharma Description and Business Overview
Table 167. Aurobindo Pharma Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Aurobindo Pharma Amlodipine Besylate Product
Table 169. Aurobindo Pharma Recent Development
Table 170. Lupin Pharmaceuticals Corporation Information
Table 171. Lupin Pharmaceuticals Description and Business Overview
Table 172. Lupin Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Lupin Pharmaceuticals Amlodipine Besylate Product
Table 174. Lupin Pharmaceuticals Recent Development
Table 175. Zydus Pharmaceuticals Corporation Information
Table 176. Zydus Pharmaceuticals Description and Business Overview
Table 177. Zydus Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Zydus Pharmaceuticals Amlodipine Besylate Product
Table 179. Zydus Pharmaceuticals Recent Development
Table 180. Oxford Pharm Corporation Information
Table 181. Oxford Pharm Description and Business Overview
Table 182. Oxford Pharm Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 183. Oxford Pharm Amlodipine Besylate Product
Table 184. Oxford Pharm Recent Development
Table 185. Wockhardt Corporation Information
Table 186. Wockhardt Description and Business Overview
Table 187. Wockhardt Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 188. Wockhardt Amlodipine Besylate Product
Table 189. Wockhardt Recent Development
Table 190. Epic Pharma Corporation Information
Table 191. Epic Pharma Description and Business Overview
Table 192. Epic Pharma Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 193. Epic Pharma Amlodipine Besylate Product
Table 194. Epic Pharma Recent Development
Table 195. CR Pharmaceutical Corporation Information
Table 196. CR Pharmaceutical Description and Business Overview
Table 197. CR Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 198. CR Pharmaceutical Amlodipine Besylate Product
Table 199. CR Pharmaceutical Recent Development
Table 200. Alkem Laboratories Corporation Information
Table 201. Alkem Laboratories Description and Business Overview
Table 202. Alkem Laboratories Amlodipine Besylate Sales (K Units), Revenue (Mil
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs